FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Enalaprilat Injection, USP
Status: Currently in Shortage
»Date first posted: 03/29/2019
»Therapeutic Categories: Cardiovascular

Expand all

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 09/09/2019)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2.5mg/2mL, vial (NDC 0143-9786-10) This presentation is temporarily on backorder. Product will be available in November/December 2019. Demand increase for the drug
1.25mg/mL, vial (NDC 0143-9787-10) This presentation is temporarily on backorder. Product will be available in November/December 2019. Demand increase for the drug

Hospira, Inc. (Reverified 09/10/2019)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1.25 mg/mL; Single Dose Glass Fliptop Vial (NDC 00409-2122-01) Next Delivery: March 2020; Estimated Recovery: June 2020 Shortage per manufacturer: Manufacturing Delay Other
2.5 mg/2 mL (1.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2122-02) Next Delivery: March 2020; Estimated Recovery: June 2020 Shortage per manufacturer: Manufacturing Delay Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English